Cassiopea Announces Results for First Half of 2021
Cassiopea S.p.A. / Key word(s): Half Year Results
29-Jul-2021 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Ad hoc announcement pursuant to Art. 53 LR
Lainate, Italy - July 29, 2021 - Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, today announced half-year results for the period ended 30 June 2021.
Key Highlights
During the first half of 2021, activities were focused on the preparations for the US commercial launch of Winlevi(R) (clascoterone cream 1 %) and advancing the development of clascoterone solution for androgenetic alopecia (AGA).
Cassiopea Reports Year End 2020 Results pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.